Healthcare products for people with a passion for living healthier
With a commitment to helping all Canadians live healthier lives
WELLCOME TO ALTIUS HEALTHCARE
OUR GOAL is to help Canadian patients achieve their wellness goals with safe, effective and affordable healthcare solutions.
We specialize in offering patients authorized generic versions of proven brand name drugs. We achieve this through strategic partnerships with brand name companies using the same formulation, production processes, and quality standards as the brand name drug.
Our Experience
Our Team’s diverse experience draws from over 40 years in producing, importing, marketing and distributing brand name and generic drugs as well as medical devices and consumer healthcare products.
Our Mission
As a uniquely Canadian Pharmaceutical company, our mission is to enhance healthcare affordability and accessibility by offering high-quality authorized generic medications. We are committed to leveraging our expertise and partnerships to provide patients with reliable, cost-effective alternatives to brand name drugs.
Our products
Discover our comprehensive range of medical products designed to support your health needs.
About Altius Healthcare Group L.P.
Learn about our commitment to providing quality healthcare solutions and compassionate patient care.
Our partnership
Explore our trusted partnerships that enhance healthcare innovation and deliver exceptional patient care.
Our Focus
With a commitment to helping Canadian live healthier lives, our priority is to introduce safe effective and affordable medicines in the Canadian marketplace. We achieve this through strategic partnerships with brand name companies who are looking for the ideal partner to extend the life cycle of their products following the loss of patent exclusivity.
Our knowledge
We are a Canadian company. We understand Canada’s pharmaceutical industry. We know how to get things done in this highly regulated marketplace. We are expert at managing product life cycle and provide a way for brand name drug manufacturers to maintain market share while offering a more affordable option to patients after the loss of patent exclusivity.